These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34093126)

  • 1. Complete Correction of Brain and Spinal Cord Pathology in Metachromatic Leukodystrophy Mice.
    Audouard E; Oger V; Meha B; Cartier N; Sevin C; Piguet F
    Front Mol Neurosci; 2021; 14():677895. PubMed ID: 34093126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
    Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
    Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy.
    Audouard E; Khefif N; Mansat C; Nelcha O; Banchi EG; Lupiet C; Farabos D; Lamaziere A; Sevin C; Piguet F
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101248. PubMed ID: 38680552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy.
    Sevin C; Benraiss A; Van Dam D; Bonnin D; Nagels G; Verot L; Laurendeau I; Vidaud M; Gieselmann V; Vanier M; De Deyn PP; Aubourg P; Cartier N
    Hum Mol Genet; 2006 Jan; 15(1):53-64. PubMed ID: 16311251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
    Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
    Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy
    St Martin T; Seabrook TA; Gall K; Newman J; Avila N; Hayes A; Kivaa M; Lotterhand J; Mercaldi M; Patel K; Rivas IJ; Woodcock S; Wright TL; Seymour AB; Francone OL; Gingras J
    J Neurosci; 2023 May; 43(19):3567-3581. PubMed ID: 36977578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
    Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
    Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
    Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy.
    Virgens MY; Siebert M; Bock H; Burin M; Giugliani R; Saraiva-Pereira ML
    Gene; 2015 Aug; 568(1):69-75. PubMed ID: 25965562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
    Sevin C; Aubourg P; Cartier N
    J Inherit Metab Dis; 2007 Apr; 30(2):175-83. PubMed ID: 17347913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts.
    Consiglio A; Martino S; Dolcetta D; Cusella G; Conese M; Marchesini S; Benaglia G; Wrabetz L; Orlacchio A; Déglon N; Aebischer P; Severini GM; Bordignon C
    J Neurol Sci; 2007 Apr; 255(1-2):7-16. PubMed ID: 17341424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype and LRP1 polymorphisms in patients with different clinical types of metachromatic leukodystrophy.
    Ługowska A; Musielak M; Jamroz E; Pyrkosz A; Kmieć T; Tylki-Szymańska A; Bednarska-Makaruk M
    Gene; 2013 Sep; 526(2):176-81. PubMed ID: 23701968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of sulfatides in the amniotic fluid supernatant: A useful tool in the prenatal diagnosis of metachromatic leukodystrophy.
    Kubaski F; Herbst ZM; Burin MG; Michelin-Tirelli K; Trapp FB; Gus R; Netto ABO; Brusius-Facchin AC; Leistner-Segal S; Sanseverino MT; de Souza CMF; Wilke MVMB; Oliveira T; Magalhães JAA; Giugliani R
    JIMD Rep; 2022 Mar; 63(2):162-167. PubMed ID: 35281662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.
    Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N
    Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.
    Mekhaeil M; Conroy MJ; Dev KK
    J Neuroimmune Pharmacol; 2023 Dec; 18(4):592-609. PubMed ID: 37924373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives.
    Pekgül F; Eroğlu-Ertuğrul NG; Bekircan-Kurt CE; Erdem-Ozdamar S; Çetinkaya A; Tan E; Konuşkan B; Karaağaoğlu E; Topçu M; Akarsu NA; Oguz KK; Anlar B; Özkara HA
    Mol Genet Metab Rep; 2020 Dec; 25():100688. PubMed ID: 33335837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
    Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
    J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches.
    Shaimardanova AA; Chulpanova DS; Solovyeva VV; Mullagulova AI; Kitaeva KV; Allegrucci C; Rizvanov AA
    Front Med (Lausanne); 2020; 7():576221. PubMed ID: 33195324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy.
    Frati G; Luciani M; Meneghini V; De Cicco S; Ståhlman M; Blomqvist M; Grossi S; Filocamo M; Morena F; Menegon A; Martino S; Gritti A
    Cell Death Dis; 2018 Jun; 9(6):698. PubMed ID: 29899471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector.
    Miyake N; Miyake K; Asakawa N; Yamamoto M; Shimada T
    Gene Ther; 2014 Apr; 21(4):427-33. PubMed ID: 24572788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.